Lunit Inc. (KOSDAQ:328130)
South Korea · Delayed Price · Currency is KRW 9,210.00
-500.00 (-5.15%)
Aug 21, 2026, 3:30 PM KST
Lunit Market Cap
Lunit has a market cap or net worth of 685.76 billion as of August 21, 2026. Its market cap has decreased by -38.61% in one year.
Market Cap
685.76B
Enterprise Value
595.61B
Revenue
91.82B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,210.00
ChartMarket Cap Chart
Since July 21, 2022, Lunit's market cap has increased from 420.31B to 685.76B, an increase of 63.16%. That is a compound annual growth rate of 12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 685.76B | -42.97% |
| Dec 30, 2025 | 1.20T | -34.88% |
| Dec 30, 2024 | 1.85T | -20.82% |
| Dec 28, 2023 | 2.33T | 540.04% |
| Dec 29, 2022 | 364.38B | -13.31% |
| Jul 21, 2022 | 420.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.72T |
| Celltrion | 44.10T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| SD Biosensor | 708.15B |
| Daewoong | 684.78B |
| Komipharm International | 670.61B |
| Myung In Pharmaceutical LTD. | 662.84B |